Market Cap 555.25M
Revenue (ttm) 170.16M
Net Income (ttm) -312.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -183.80%
Debt to Equity Ratio 0.00
Volume 1,653,600
Avg Vol 1,173,662
Day's Range N/A - N/A
Shares Out 65.32M
Stochastic %K 31%
Beta 1.78
Analysts Hold
Price Target $8.67

Company Profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the re...

Industry: Biotechnology
Sector: Healthcare
Phone: 877 422 5362
Address:
27 Drydock Avenue, 8th Floor, Boston, United States
ChineseTakeeout
ChineseTakeeout Aug. 19 at 8:14 PM
$DNA Its really incredible how terrible jason is as a ceo considering what their closest partner $TWST is able to do. This shitco was really just all smoke and mirrors
0 · Reply
STACKD0E
STACKD0E Aug. 19 at 7:53 PM
$DNA 🙃 ✨️
0 · Reply
the_end
the_end Aug. 19 at 7:10 PM
$DNA OpenAI has launched NextGenAI, a consortium of 15 research institutions that will integrate AI into education and accelerate scientific discoveries. few months later .... Ginkgo Bioworks expanded its autonomous lab network with four new cloud-accessible lab initiatives at Caltech, MIT, Maryland, Northwestern. openai will acquire ginkgo bioworks ...
2 · Reply
Kar777
Kar777 Aug. 19 at 6:28 PM
$DNA golden age of bio will start soon. They just need to raise money ti last 3 more years. Hope interest rates come down next year.
0 · Reply
the_end
the_end Aug. 19 at 5:23 PM
$DNA let the day pass. anthropic twist bio partnership helped ginkgo with some run. openai ginkgo news did not take ginkgo anywhere .... infact it hit correction multiple times since then. twist on the other hand has grown from 40 to 140 .... remember there is no near term revenue for ginkgo .... the CFO and ceo themselves spoke about it in the earnings. be careful of pump and dump ...
0 · Reply
Zephix
Zephix Aug. 19 at 3:25 PM
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 19 at 3:13 PM
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Aug. 19 at 3:04 PM
0 · Reply
kp8claw
kp8claw Aug. 19 at 2:50 PM
$DNA | $7.33 | Vol: 627K | RE·RVOL=0.50·F=41M | MUP_1 | Long
0 · Reply
the_end
the_end Aug. 19 at 2:35 PM
$DNA lol ginkgo did not work with Merck wrt cancer, ginkgo did not work with moderna wrt cancer, still i saw a double digit gain, on the anniversary day. have fun while it lasts, it partners with pfizer and Astella wrt oncology but pfizer left for china ... so ....
0 · Reply
Latest News on DNA
Ginkgo Bioworks Holdings Earnings Call Transcript: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q2 2026


Ginkgo Bioworks Holdings Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Ginkgo Bioworks Holdings Earnings release: Q2 2026


Ginkgo Bioworks Holdings Slides: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Ginkgo Bioworks Holdings Slides: Q2 2026


Ginkgo Bioworks Holdings Quarterly report: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 13 days ago

Ginkgo Bioworks Holdings Quarterly report: Q2 2026


Ginkgo Bioworks Holdings Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q1 2026


Ginkgo Bioworks Holdings Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Ginkgo Bioworks Holdings Earnings release: Q1 2026


Ginkgo Bioworks Holdings Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Ginkgo Bioworks Holdings Quarterly report: Q1 2026


Ginkgo Bioworks Holdings Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Ginkgo Bioworks Holdings Slides: Q1 2026


Ginkgo Bioworks Holdings Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Ginkgo Bioworks Holdings Proxy statement: Proxy filing


Ginkgo Bioworks Holdings Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Ginkgo Bioworks Holdings Proxy statement: Proxy filing


Ginkgo Bioworks Holdings Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q4 2025


Ginkgo Bioworks Holdings Annual report: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Ginkgo Bioworks Holdings Annual report: Q4 2025


Ginkgo Bioworks Holdings Earnings release: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Ginkgo Bioworks Holdings Earnings release: Q4 2025


Ginkgo Bioworks Holdings Slides: Q4 2025

Feb 26, 2026, 4:30 PM EST - 6 months ago

Ginkgo Bioworks Holdings Slides: Q4 2025


Ginkgo Bioworks Holdings Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q3 2025


Ginkgo Bioworks Holdings Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Ginkgo Bioworks Holdings Quarterly report: Q3 2025


Ginkgo Bioworks Holdings Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Ginkgo Bioworks Holdings Earnings release: Q3 2025


Ginkgo Bioworks Holdings Slides: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Ginkgo Bioworks Holdings Slides: Q3 2025


Ginkgo Bioworks Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:05 PM EST - 10 months ago

Ginkgo Bioworks Reports Third Quarter 2025 Financial Results


Ginkgo Bioworks Holdings Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q2 2025


Ginkgo Bioworks Holdings Quarterly report: Q2 2025

Aug 7, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Quarterly report: Q2 2025


Ginkgo Bioworks Holdings Earnings release: Q2 2025

Aug 7, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Earnings release: Q2 2025


Ginkgo Bioworks Holdings Slides: Q2 2025

Aug 7, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Slides: Q2 2025


Twist Bioscience and Ginkgo Bioworks Revise Collaboration

May 8, 2025, 8:00 AM EDT - 1 year ago

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

TWST


Ginkgo Bioworks Holdings Earnings Call Transcript: Q1 2025

May 6, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q1 2025


Ginkgo Bioworks Holdings Quarterly report: Q1 2025

May 6, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Quarterly report: Q1 2025


Ginkgo Bioworks Holdings Earnings release: Q1 2025

May 6, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Earnings release: Q1 2025


Ginkgo Bioworks Holdings Slides: Q1 2025

May 6, 2025, 5:30 PM EDT - 1 year ago

Ginkgo Bioworks Holdings Slides: Q1 2025


Ginkgo Bioworks Reports First Quarter 2025 Financial Results

May 6, 2025, 5:00 PM EDT - 1 year ago

Ginkgo Bioworks Reports First Quarter 2025 Financial Results


Ginkgo Bioworks Holdings Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Ginkgo Bioworks Holdings Proxy statement: Proxy Filing


Ginkgo Bioworks Holdings Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Ginkgo Bioworks Holdings Proxy statement: Proxy Filing


Ginkgo Bioworks Holdings Earnings Call Transcript: Q4 2024

Feb 25, 2025, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q4 2024


Ginkgo Bioworks Holdings Annual report: Q4 2024

Feb 25, 2025, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Annual report: Q4 2024


Ginkgo Bioworks Holdings Earnings release: Q4 2024

Feb 25, 2025, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Earnings release: Q4 2024


Ginkgo Bioworks Holdings Slides: Q4 2024

Feb 25, 2025, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Slides: Q4 2024


Ginkgo Bioworks Holdings Slides: FY 2025

Jan 16, 2025, 1:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Slides: FY 2025


Ginkgo Bioworks Holdings Earnings Call Transcript: Q3 2024

Nov 12, 2024, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Earnings Call Transcript: Q3 2024


Ginkgo Bioworks Holdings Quarterly report: Q3 2024

Nov 12, 2024, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Quarterly report: Q3 2024


Ginkgo Bioworks Holdings Earnings release: Q3 2024

Nov 12, 2024, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Earnings release: Q3 2024


Ginkgo Bioworks Holdings Slides: Q3 2024

Nov 12, 2024, 5:30 PM EST - 1 year ago

Ginkgo Bioworks Holdings Slides: Q3 2024


Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 5:01 PM EST - 1 year ago

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results


ChineseTakeeout
ChineseTakeeout Aug. 19 at 8:14 PM
$DNA Its really incredible how terrible jason is as a ceo considering what their closest partner $TWST is able to do. This shitco was really just all smoke and mirrors
0 · Reply
STACKD0E
STACKD0E Aug. 19 at 7:53 PM
$DNA 🙃 ✨️
0 · Reply
the_end
the_end Aug. 19 at 7:10 PM
$DNA OpenAI has launched NextGenAI, a consortium of 15 research institutions that will integrate AI into education and accelerate scientific discoveries. few months later .... Ginkgo Bioworks expanded its autonomous lab network with four new cloud-accessible lab initiatives at Caltech, MIT, Maryland, Northwestern. openai will acquire ginkgo bioworks ...
2 · Reply
Kar777
Kar777 Aug. 19 at 6:28 PM
$DNA golden age of bio will start soon. They just need to raise money ti last 3 more years. Hope interest rates come down next year.
0 · Reply
the_end
the_end Aug. 19 at 5:23 PM
$DNA let the day pass. anthropic twist bio partnership helped ginkgo with some run. openai ginkgo news did not take ginkgo anywhere .... infact it hit correction multiple times since then. twist on the other hand has grown from 40 to 140 .... remember there is no near term revenue for ginkgo .... the CFO and ceo themselves spoke about it in the earnings. be careful of pump and dump ...
0 · Reply
Zephix
Zephix Aug. 19 at 3:25 PM
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 19 at 3:13 PM
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Aug. 19 at 3:04 PM
0 · Reply
kp8claw
kp8claw Aug. 19 at 2:50 PM
$DNA | $7.33 | Vol: 627K | RE·RVOL=0.50·F=41M | MUP_1 | Long
0 · Reply
the_end
the_end Aug. 19 at 2:35 PM
$DNA lol ginkgo did not work with Merck wrt cancer, ginkgo did not work with moderna wrt cancer, still i saw a double digit gain, on the anniversary day. have fun while it lasts, it partners with pfizer and Astella wrt oncology but pfizer left for china ... so ....
0 · Reply
STACKD0E
STACKD0E Aug. 19 at 1:41 PM
$IDN $DNA 👁️
0 · Reply
WantedToRetireEarly
WantedToRetireEarly Aug. 19 at 1:40 PM
$TWST $DNA Twist as usual the only serious synthetic bio company out there https://x.com/twistbioscience/status/2090061378455318938?s=46&t=jKXapJZhCmbNduU3W_BgJQ
0 · Reply
TrentEB
TrentEB Aug. 19 at 1:33 PM
$DNA Moderna news has to be good for dna. It is in the name
0 · Reply
the_end
the_end Aug. 19 at 11:29 AM
$DNA remembe, ginkgo bioworks did not collaborate with moderna after Covid ...
0 · Reply
the_end
the_end Aug. 19 at 5:58 AM
0 · Reply
Ramseydog
Ramseydog Aug. 19 at 1:41 AM
🚀 $NICH is quietly building something bigger than another supplement brand — NutraVeri is becoming the infrastructure layer for the entire category. In ~60 seconds founders get a free, deterministic NutraVeri Score across 6 dimensions (formula strength, ingredient evidence, claim risk, dose, label readiness, market fit) built on actual FDA/FTC warning letters and public data. No black-box AI, no account required. Recent moves: expanding into full commercialization (warehousing, fulfillment, distribution), active JV talks with a major U.S. cGMP facility, and now opening the Label Readiness Engine to retired NFL players who want to own their own products instead of just endorsing someone else’s. From concept → scored → manufactured → customer doorstep. That’s the play in a tightening regulatory environment. Watch this one. 💪 $CRDL $AIMN $VNRX $DNA #NICH #NutraVeri #Supplements #Wellness #cGMP #Biotech https://grok.com/share/bGVnYWN5_c2efe96f-46dc-4d5e-8fa7-a3e5d32a1679
0 · Reply
the_end
the_end Aug. 18 at 6:17 PM
$DNA many say they blocked me or muted me, still read my posts. i was blocked my the ceo on X , at that time the stock was around 12. i have been blocked on many social media platforms and Fintech platforms .... for some reason, stocktwits banned me once but allowed my second account. but I have been right , all the time. this will go under 5 and it will get much more miserable .... look at twist biosciences and look at ginkgo bioworks. cathie woods invested in both, but left ginkgo for good. look at where both are now. it entered RUT growth stocks but within few months was thrown out AGAIN. shyam sankar did not wish to continue even as a board member, forget chair of board. all bill gates linked companies have suffered after his revelation around the island. he visited rwanda, there was ebola outbreak, there is measles outbreak .... he wants to cure malaria ... so ...
0 · Reply
madnessofcrowds
madnessofcrowds Aug. 18 at 5:38 PM
$DNA a little too quiet at the lows. thinking we might see some interesting action into the close.
1 · Reply
madnessofcrowds
madnessofcrowds Aug. 18 at 5:28 PM
$DNA bought 6.52
0 · Reply
the_end
the_end Aug. 18 at 5:25 PM
$DNA we will hit 2 year anniversary on aug 20 when it went into reverse split 1:40. technically we remain under $1.X for almost 30 months or more now. WOW
0 · Reply
the_end
the_end Aug. 18 at 5:02 PM
$DNA Economists at the European Central Bank warn high stock market valuations are likely to suffer a correction, even if they fairly reflect the ways in which AI will transform society. this will impact ginkgo pivot severely ... it tried to ride the ai train too at the wrong time.
0 · Reply
the_end
the_end Aug. 18 at 4:58 PM
$DNA as expected. they don't value anything what ginkgo is doing for now because it is clear none of its effort will yield any short term revenue but only cash burn. the revenue will take much longer , so the pricing would barely match it's cash in hand. then there is inflation risk , cash burn would be worse given things will become expensive to buy but revenue realisation will be in the future. we might hit below 5 this time. i have been long associated with ginkgo that I called 5 when it was 9, this time it will go lower. the only positive is it still gets govt money ... and my snap exp says, institutions go after companies with excessive voting rights but still burning a lot of cash. short term is bearish ... glta
1 · Reply